Patent · US Active

Mutant pore

US11104709B2 · kind B2 · utility

18Cited by
36References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 6, 2017
Grant dateAug 31, 2021
Priority date—
Expiry dateApr 6, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/43504
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to mutant forms of lysenin. The invention also relates to analyte characterisation using the mutant forms of lysenin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.